John B. Villeneuve

John Villeneuve practices at Reading Hospital in West Reading, Pennsylvania, part of Tower Health.

John Villeneuve's NPI, 1447201827, was assigned on May 12, 2006. John Villeneuve graduated from University of Southern California Keck School of Medicine in 1991. John Villeneuve holds Pennsylvania license MD064792L.

John Villeneuve's primary practice is Reading Hospital, at 420 S 5th Avenue, West Reading, PA 19611 in Berks County. The practice phone is (610) 988-8000.

John Villeneuve's primary practice is Reading Hospital in West Reading, Pennsylvania, part of Tower Health. John Villeneuve is also affiliated with Penn State Health St. Joseph Medical Center. The medical group on file is Tower Health Medical Group. Dmand AI also links John Villeneuve to 2 more hospitals, 2 group practices and clinics, 2 medical groups and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where John Villeneuve practices, 7 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is John Villeneuve's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. John Villeneuve is licensed in Pennsylvania.

CMS data shows 519 Medicare services from John Villeneuve across 5 procedure codes in 2024, for 188 Medicare patients. Medicare paid $30,238 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 188 Medicare patients who saw John Villeneuve in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts John Villeneuve's median patient age at 67, with 100% women.

In 2024, John Villeneuve wrote 508 Medicare Part D claims for 98 patients. 78% of them were for generic drugs. CMS names the drug for 461 of them, across 15 drugs with 11 or more claims each, at $1,660,699 in total drug cost. In 2023, CMS named 271 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for John Villeneuve for performance year 2024, reported as part of a group. John Villeneuve accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 25 procedures of removal of the uterus by John Villeneuve, more than 95% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 11 general payments to John Villeneuve from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Clovis Oncology, Inc. paid the most, $125.

John Villeneuve graduated from University of Southern California Keck School of Medicine in 1991.